Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis

Geng D, Dandan Geng, Shaobin Wei, Wei S, Cheng W, Wenxiu Cheng, Zhong H, Hanzhi Zhong, Keke Zhang, Zhang K, Ke-Ke Zhang
Complementary therapies in clinical practice · 2025 · vol. 61 , pp. 102020 · doi:10.1016/j.ctcp.2025.102020 · PMID:41005283 · W4414036566
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This Bayesian network meta-analysis compared the clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND AND PURPOSE: Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) after laparoscopic surgery. However, the optimal CPM option remains debatable. This network meta-analysis aimed to objectively compare the efficacy and safety of different CPM options for endometriosis after laparoscopic surgery. METHODS: Randomized controlled trials (RCTs) published up to June 2024 were searched in relevant databases. The risk of bias was assessed via the Cochrane bias risk assessment tool 2.0. The Bayesian network meta-analysis was conducted by R version 4.2.3 and STATA version 17.0. RESULTS: A total of 47 RCTs were included. In terms of improving overall response rate, Guizhi Fuling pill combined with hormones was the most likely to be the best choice of CPM for endometriosis after laparoscopic surgery. Dan'e Fukang decoction had the best effect in improving the rate of pregnancy. Sanjie Zhentong capsule was the most effective in reducing the recurrence rate and estrogen (E2) levels. Xuefu Zhuyu capsule was the most effective in reducing the level of follicle-stimulating hormone (FSH) and the incidence of adverse reactions. Fuke Qianjin capsule was the most effective in reducing luteinizing hormone (LH) levels. Xiaojin capsule showed optimal efficacy in reducing serum carbohydrate antigen 125 (CA125) levels. None of the included studies reported serious adverse reactions. CONCLUSION: CPMs can effectively improve overall response rate and reduce the incidence of adverse reactions after laparoscopic surgery for endometriosis. More high-quality, large-scale RCTs are required to validate the efficacy and safety of these CPMs.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

Cited by (1)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-26T06:04:27.736466+00:00
License: CC0 · commercial use OK